Disruption of the mouse cyclooxygenase 1 gene: Characteristics of the mutant and areas of future study

Advances in Experimental Medicine and Biology

Volumn 407, Issue , 1996, Pages 87-92

  Langenbach, Robert ^a   Morham, Scott G ^b   Tiano, Howard F ^a   Loftin, Charles D ^a   Ghanayem, Burhan I ^a   Chulada, Patrica C ^a   Mahler, Joel F ^a   Davis, Barbara J ^a   Lee, Christopher A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; ENZYME ANALYSIS; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; FEMALE; GENE TARGETING; GENES; GENOTYPE; INFLAMMATION; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REPRODUCTION; STOMACH ULCER;

EID: 0030417714     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (28)

1. DeWitt, D.L. , Meade, E.A., and Smith, W.L., 1993, PGH synthase isoenzyme selectivity:the potential for safer nonsteroidal antiinflammatory drugs, Amer. J. Medicine 95 (suppl. 12A):40S.
2. Dinchuk, J.E., Car, B.C., Focht, R.J., Johnston, J.J., Jaffee, B.D., Covington, M.B., Contel, N.R., Eng, V.M., Collins, R.J., Czernak, P.M., Gorry, S.A., and Trzaskos, J.M., 1995, Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II, Nature 378:406.
3. Funk, C.D., Funk, L.B., Kennedy, M.E., Pong, A.S., and Fitzgerald, G.A., 1991, Human platelet/erythroleukemia cell prostaglandin G/H synthase:cDNA cloning, expression, and gene chromosomal assignment, FASEB J. 5:2304.
4. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S., and DuBois, R.N., 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology 107:1183.
5. Gad, S.C., Dunn, B.J., Dobbs, D.W., Reilly, C., and Walsh, R.D., 1986, Development and validation of an alternative dermal sensitization test:the mouse ear swelling test (MEST), Toxicol. Appl. Pharmacol. 84:93.
6. Harris, R.E., Namboodiri, K. Stellman, S.D., and Wynder, E.L., 1995, Breast cancer and NSAID use:heterogeneity of effect in a case-control study, Preventive Medicine 24:119.
7. Kargman, S.L., Oneill, G.P., Vickers, P.J., Evans, J.F., Mancini, J.A., and Jothy, S., 1995, Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer, Cancer Res. 55:2556.
8. Kelly, R.W., 1994, Pregnancy maintainance and parturition:the role of prostaglandin in manipulating the immune and inflammatory response, Endocrine Rev. 15:684.
9. Kujubu, D.A., Fletcher, B.S., Varnum, B.C., Lim, R.W., and Herschman, H.R., 1991, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J. Biol. Chem., 266:12866.
10. Langenbach, R., Morham, S.G., Tiano, H.F., Loftin, C.D., Ghanayem, B.I., Chulada, P.C., Mahler, J.F., Lee, C.A., Goulding, E.H., Kluckman, K.D., Kim, H.S. and Smithies, O., 1995, Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell 83:483.
11. Marnett, L.J., 1992, Aspirin and the potential role of prostaglandins in colon cancer, Cancer Res. 52:5575.
12. Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K.M., Smith, W.G., Isakson, P.C., and Seibert, K., 1994, Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic, Proc. Natl. Acad. Sci. USA 91:3228.
13. Moon, R.C., Kelloff, G.J., Detrisac, C.J., Steele, V.E., Thomas, C.F., and Sigman, C.C., 1993, Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam, Carcinogenesis 14:1487.
14. Morham, S.G., Langenbach, R., Loftin, C.D., Tiano, H.F., Vouloumanos, N., Jennette, J.C., Mahler, J.F., Kluckman, K.D., Ledford, A., Lee, C.A., and Smithies, O., 1995, Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell 83:472.
15. Moser, A.R., Pitít, H.C. and Dove, W.F., 1990, A dominant mutation that predisposes to intestional neoplasia in the mouse, Science 247:322.
16. Muller-Decker, K., Scholz, K., Marks, F., and Furstenberger, G., 1995, Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis, Mol. Carcinogen. 12:31.
17. Opas, E.E., Bonney, R.J., and Humes, J.L., 1985, Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid, J. Invest. Dermatol. 84: 253.
18. Pasricha, P.J., Bedi, A., O'Connor, K., Rashid, A., Aktar, A.J., Zahurak, M.L., Piantadosi, S., Hamilton, S.R. and Giardello, F.M., 1995, The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis, Gastroenterology 109:994.
19. Rao, C.V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B.S., 1995, Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent, Cancer Res. 55:1464.
20. Robert, A., 1975, An intestinal disease produced experimentally by a prostaglandin deficiency, Gastroenterology 69: 1045.
21. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P., 1994, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl. Acad. Sci. USA 91:12013.
22. Sirois, J., Simmons, D.L., and Richards, J.S., 1992, Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro, J. Biol. Chem. 267:11586.
23. Tennant, R.W., French, J.E., and Spalding, J.W. , 1995, Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models, Envir. Health Pers. 103:942.
24. Thorburn, G.D., 1991, The placenta, prostaglandins and parturition:a review, Reprod. Fertil. Dev. 3:277.
25. Thun, M.J., Namboodiri, M.M., Calle, E.E., Flanders, W.D., and Heath, C.W.J., 1993, Aspirin use and risk of fatal cancer, Cancer Res. 53:1322.
26. Tsujii, M. and DuBois, R.N., 1995, Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell 83:493.
27. Vane, J., 1994, Pharmacology - towards a better aspirin, Nature 367, 215.
28. Vane, J.R., Mitchell, J.A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D.A., 1994, Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc. Natl. Acad. Sci. USA 91:2046.